Sun Pharma Seeks To Acquire German GenericsMaker Stada, Sources Say
This article was originally published in PharmAsia News
Executive Summary
Sun Pharmaceutical Industries is eyeing acquisition of Germany’s Stada Arzneimittel, a maker of generics, as part of a plan to invest as much as $1 billion in European companies, according to sources.